chr7-105470697-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_019042.5(PUS7):āc.1389A>Gā(p.Ala463=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00228 in 1,594,362 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.012 ( 30 hom., cov: 33)
Exomes š: 0.0013 ( 24 hom. )
Consequence
PUS7
NM_019042.5 synonymous
NM_019042.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.115
Genes affected
PUS7 (HGNC:26033): (pseudouridine synthase 7) Enables enzyme binding activity and pseudouridine synthase activity. Involved in several processes, including pseudouridine synthesis; regulation of hematopoietic stem cell differentiation; and regulation of mesoderm development. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 7-105470697-T-C is Benign according to our data. Variant chr7-105470697-T-C is described in ClinVar as [Benign]. Clinvar id is 785229.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.115 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0117 (1790/152356) while in subpopulation AFR AF= 0.0408 (1696/41578). AF 95% confidence interval is 0.0392. There are 30 homozygotes in gnomad4. There are 871 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 30 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PUS7 | NM_019042.5 | c.1389A>G | p.Ala463= | synonymous_variant | 11/16 | ENST00000469408.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PUS7 | ENST00000469408.6 | c.1389A>G | p.Ala463= | synonymous_variant | 11/16 | 1 | NM_019042.5 | P1 | |
PUS7 | ENST00000356362.6 | c.1389A>G | p.Ala463= | synonymous_variant | 11/16 | 2 | P1 | ||
PUS7 | ENST00000478208.1 | n.209A>G | non_coding_transcript_exon_variant | 2/2 | 3 | ||||
PUS7 | ENST00000481939.5 | c.1325+64A>G | intron_variant, NMD_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0117 AC: 1777AN: 152238Hom.: 31 Cov.: 33
GnomAD3 genomes
AF:
AC:
1777
AN:
152238
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00310 AC: 767AN: 247446Hom.: 14 AF XY: 0.00230 AC XY: 308AN XY: 133820
GnomAD3 exomes
AF:
AC:
767
AN:
247446
Hom.:
AF XY:
AC XY:
308
AN XY:
133820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00128 AC: 1847AN: 1442006Hom.: 24 Cov.: 30 AF XY: 0.00113 AC XY: 804AN XY: 714248
GnomAD4 exome
AF:
AC:
1847
AN:
1442006
Hom.:
Cov.:
30
AF XY:
AC XY:
804
AN XY:
714248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0117 AC: 1790AN: 152356Hom.: 30 Cov.: 33 AF XY: 0.0117 AC XY: 871AN XY: 74516
GnomAD4 genome
AF:
AC:
1790
AN:
152356
Hom.:
Cov.:
33
AF XY:
AC XY:
871
AN XY:
74516
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2018 | - - |
PUS7-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at